Haris Bin Tahir

12PUBLICATIONS
25CO-AUTHORS
Pharmaceutical delivery technologiesCardiology (incl. cardiovascular diseases)Gene and molecular therapyRespiratory diseasesPopulation trends and policies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
Comparison of the Safety and Effectiveness of Apixaban Versus Rivaroxaban in Acute Venous Thromboembolism: A Propensity-Matched Real-World TriNetX Study with Obesity and Cancer Subgroup Analyses.

|Jul 23, 2026
Comparative outcomes of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and liver cirrhosis: A propensity score matched TriNetX analysis.

|Jul 15, 2026
GLP-1 Receptor Agonists or Dual GLP-1/GIP Receptor Agonists vs. SGLT2 Inhibitors in Patients with Atrial Fibrillation and HFpEF: A Propensity-Matched Real-World Analysis.

|Jun 26, 2026
Clinical Outcomes of GLP-1 Receptor Agonist and SGLT2 Inhibitor Combination Therapy in Heart Failure: A Real-World Propensity-Matched TriNetX Analysis.

|Jun 25, 2026
Cardiovascular Outcomes with Colchicine in Coronary Artery Disease and HFpEF: A Propensity-Matched TriNetX Analysis.

|Jun 22, 2026
Early Rhythm Versus Rate Control in Older Adults With New-Onset Atrial Fibrillation: A Propensity Score-Matched Analysis.

Pageof 2

Frequent Collaborators

5 joint publications

Mohammad Omar Butt

5 joint publications

Najam Gohar

5 joint publications

Muhammad Hassan

4 joint publications

Madeeha Shafqat